Bemotrizinol and the modernization of US sunscreen regulation
Umayr R Shaikh, Christopher G Richter, Leela K Raj, Afrin Mirza, Harold William Higgins, Jane M Grant-Kels · 2026
Read Bemotrizinol and the modernization of US sunscreen regulation by Umayr R Shaikh, Christopher G Richter, Leela K Raj, Afrin Mirza, Harold William Higgins, Jane M Grant-Kels (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13427495.txt.
Description
Umayr R. Shaikh and coauthors examine bemotrizinol's approval as a turning point for United States sunscreen regulation in a 2026 article. The Food and Drug Administration finalized an order adding the filter to the over-the-counter monograph. It is classed as safe and effective up to six percent for adults and children from six months old. This is the first new ultraviolet filter since 1999. Sold abroad as Tinosorb S after two decades of use in Europe, Australia, and Asia, it offers broad coverage, low absorption, and standout photostability.
The durable significance may be procedural: the approval is the first from a rebuilt regulatory system designed to prevent such decades-long delays. Sunscreen reform advocates gain a precedent case.
Catalog record
| CREATOR | Umayr R Shaikh, Christopher G Richter, Leela K Raj, Afrin Mirza, Harold William Higgins, Jane M Grant-Kels |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3777 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |